Voya Investment Management LLC grew its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 180.5% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 110,405 shares of the company's stock after buying an additional 71,051 shares during the quarter. Voya Investment Management LLC owned approximately 0.05% of Bath & Body Works worth $3,347,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. T. Rowe Price Investment Management Inc. increased its position in Bath & Body Works by 7.6% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company's stock valued at $334,029,000 after purchasing an additional 781,681 shares during the period. Victory Capital Management Inc. lifted its holdings in Bath & Body Works by 14,732.0% in the first quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock worth $206,119,000 after buying an additional 6,752,274 shares during the period. Alliancebernstein L.P. lifted its holdings in Bath & Body Works by 4.7% in the first quarter. Alliancebernstein L.P. now owns 5,422,058 shares of the company's stock worth $164,397,000 after buying an additional 243,611 shares during the period. AQR Capital Management LLC lifted its holdings in Bath & Body Works by 267.8% in the first quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company's stock worth $121,073,000 after buying an additional 2,907,506 shares during the period. Finally, GMT Capital Corp lifted its holdings in Bath & Body Works by 7.3% in the first quarter. GMT Capital Corp now owns 3,737,700 shares of the company's stock worth $113,327,000 after buying an additional 255,600 shares during the period. Institutional investors own 95.14% of the company's stock.
Bath & Body Works Stock Performance
Shares of BBWI stock traded up $0.44 during mid-day trading on Tuesday, hitting $26.34. The company's stock had a trading volume of 1,081,097 shares, compared to its average volume of 5,406,200. Bath & Body Works, Inc. has a 52-week low of $24.93 and a 52-week high of $41.87. The business has a 50-day moving average price of $29.46 and a 200 day moving average price of $29.69. The stock has a market cap of $5.43 billion, a price-to-earnings ratio of 7.81, a PEG ratio of 0.86 and a beta of 1.49.
Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting the consensus estimate of $0.37. The company had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.Bath & Body Works's revenue for the quarter was down .8% on a year-over-year basis. During the same period last year, the company earned $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Equities research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were paid a dividend of $0.20 per share. The ex-dividend date was Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 3.0%. Bath & Body Works's payout ratio is currently 23.74%.
Analysts Set New Price Targets
Several brokerages have recently issued reports on BBWI. Telsey Advisory Group reissued an "outperform" rating and issued a $38.00 target price on shares of Bath & Body Works in a research report on Thursday, August 28th. Wall Street Zen cut shares of Bath & Body Works from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Barclays boosted their target price on shares of Bath & Body Works from $30.00 to $32.00 and gave the company an "equal weight" rating in a report on Friday, August 29th. UBS Group lowered their price target on shares of Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a research report on Friday, August 29th. Finally, Morgan Stanley decreased their target price on shares of Bath & Body Works from $19.00 to $18.00 and set an "overweight" rating for the company in a research note on Friday, September 12th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $39.69.
Get Our Latest Stock Analysis on BBWI
About Bath & Body Works
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Read More

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.